Marquette Asset Management’s DexCom DXCM Stock Holding History

Marquette Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49K	Sell	37 -34	-48%	-$2.27K	﹤0.01%	557
2026 Q1	$4.46K	Buy	+71	New	+$4.94K	﹤0.01%	377
2025 Q4	–	Sell	-33	Closed	-$2.22K	–	754
2025 Q3	$2.22K	Buy	+33	New	+$2.61K	﹤0.01%	521
2022 Q2	–	Sell	-4	Closed	-$1K	–	333
2022 Q1	$1K	Buy	+4	New	+$438	﹤0.01%	294

Other funds holding DXCM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DCP

DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Marquette Asset Management's DXCM Position: Q2 2026 in Review

Marquette Asset Management reduced its DexCom (DXCM) stake by 48% in Q2 2026, selling an estimated $2.27K and leaving 37 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Marquette Asset Management first reported a position in DXCM in Q1 2022 and has held it in 4 quarters since. The position peaked at $4.46K in Q1 2026. 463 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Marquette Asset Management held 37 shares of DexCom worth $2.49K as of Q2 2026.
Marquette Asset Management sold 34 DexCom shares in Q2 2026, an estimated $2.27K.
DexCom made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #557 holding.
Marquette Asset Management first reported a position in DexCom in Q1 2022 and has held it in 4 quarters since.
Marquette Asset Management's DexCom position peaked at $4.46K in Q1 2026.
463 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.